Found: 7
Select item for more details and to access through your institution.
Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 5, p. 631, doi. 10.3390/ph15050631
- By:
- Publication type:
- Article
The Wheel of p53 Helps to Drive the Immune System.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7645, doi. 10.3390/ijms24087645
- By:
- Publication type:
- Article
Transcriptome Analysis of Cells Exposed to Actinomycin D and Nutlin-3a Reveals New Candidate p53-Target Genes and Indicates That CHIR-98014 Is an Important Inhibitor of p53 Activity.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 20, p. 11072, doi. 10.3390/ijms222011072
- By:
- Publication type:
- Article
Germline Variants in Angiogenesis-Related Genes Contribute to Clinical Outcome in Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1844, doi. 10.3390/cancers14071844
- By:
- Publication type:
- Article
Activation of the atypical NF-κB pathway induced by ionizing radiation is not affected by the p53 status.
- Published in:
- Acta Biochimica Polonica, 2022, v. 69, n. 1, p. 205, doi. 10.18388/abp.2020_5942
- By:
- Publication type:
- Article
The Strong Activation of p53 Tumor Suppressor Drives the Synthesis of the Enigmatic Isoform of DUSP13 Protein.
- Published in:
- Biomedicines, 2024, v. 13, n. 7, p. 1449, doi. 10.3390/biomedicines12071449
- By:
- Publication type:
- Article
Strong activation of p53 by actinomycin D and nutlin-3a overcomes the resistance of cancer cells to the pro-apoptotic activity of the FAS ligand.
- Published in:
- Apoptosis, 2024, v. 29, n. 9/10, p. 1515, doi. 10.1007/s10495-024-02000-0
- By:
- Publication type:
- Article